Nearly one-third of Covaxin recipients report adverse effects: Study
A significant number of individuals who received Bharat Biotech’s Covaxin vaccine have reported adverse side effects, a study by SpringerLink has revealed.
This comes weeks after Anglo-Swedish drugmaker AstraZeneca acknowledged similar issues with its Covid-19 vaccine.
As per Economic Times, the study published on SpringerLink, revealed that nearly one-third of participants in an observational study on Covaxin experienced adverse events of special interest (AESI).
The study highlighted that female adolescents and individuals with a history of allergies are at a higher risk of AESIs after receiving COVID-19.
Among the 1,024 participants, which included 635 adolescents and 291 adults, 304 adolescents (47.9%) and 124 adults (42.6%) reported viral upper respiratory tract infections...